Chandler Robinson has sold MNPR and made no open-market buys since Sep 2026
Chief Executive Officer at Monopar Therapeutics Inc.
SEC CIK 0001727334 · Filings on SEC.gov ↗
$0Bought
$2.6MSold
NoneLast buy
Every filing
1 filing since Sep 2026, newest first
Filings come from SEC EDGAR. Not investment advice.